Sofie Mohlin

13PUBLICATIONS
55CO-AUTHORS
Digital processor architecturesCancer therapy (excl. chemotherapy and radiation therapy)Functional materialsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 03, 2026
Why and when should we choose digital PCR?

|Jun 18, 2025
Combined targeting of PRDX6 and GSTP1 as a potential differentiation strategy for neuroblastoma treatment.

Judit Liaño-Pons, Elisa Garde-Lapido, Fenja L Fahrig

|Mar 28, 2025
Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines.

Sujeethkumar Prithiviraj, Alejandro Garcia Garcia, Karin Linderfalk

|Feb 14, 2025
Chemical profiling of surviving cancer cells using ToF-SIMS and MCR analysis discriminates cell components.

Auraya Manaprasertsak, Robin Rydbergh, Qicheng Wu

|Jun 21, 2024
MOXD1 is a lineage-specific gene and a tumor suppressor in neuroblastoma.

Elina Fredlund, Stina Andersson, Elien Hilgert

|Feb 22, 2024
Drug-resilient Cancer Cell Phenotype Is Acquired via Polyploidization Associated with Early Stress Response Coupled to HIF2α Transcriptional Regulation.

Christopher Carroll, Auraya Manaprasertsak, Arthur Boffelli Castro

Pageof 3

Frequent Collaborators

4 joint publications

Emma U Hammarlund

3 joint publications

Marie Arsenian-Henriksson

2 joint publications

Niklas Engström

2 joint publications

Sonia Martinez